Wordt geladen...
Could clinical photochemical internalisation be optimised to avoid neuronal toxicity?
Photochemical Internalisation (PCI) is a novel drug delivery technology in which low dose photodynamic therapy (PDT) can selectively rupture endo/lysosomes by light activation of membrane-incorporated photosensitisers, facilitating intracellular drug release in the treatment of cancer. For PCI to be...
Bewaard in:
| Gepubliceerd in: | Int J Pharm |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier/North-Holland Biomedical Press
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5571751/ https://ncbi.nlm.nih.gov/pubmed/28579544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2017.05.071 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|